Nivagen Pharmaceuticals Inc recalls Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, I…
- Recall date
- September 24, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0001-2025
- FDA classification
- Class II
- Brand / firm
- Nivagen Pharmaceuticals Inc
- Sold / distributed
- Nationwide within the U.S
Why it was recalled
Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA, Manufactured by: Umedica Laboratories Pvt Ltd., Vapi Gujarat 396195, India, NDC: 75834-257-01.
Get recall alerts
Free email alert whenever Nivagen Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Nivagen Pharmaceuticals Inc